{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:17:15Z","timestamp":1770977835015,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian Pediatr"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s13312-025-00015-7","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T20:07:19Z","timestamp":1742674039000},"page":"300-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cannabinoid Use in Pediatric Epilepsy"],"prefix":"10.1007","volume":"62","author":[{"given":"Robyn","family":"Whitney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Jauhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3320-2851","authenticated-orcid":false,"given":"Puneet","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,21]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1017\/cjn.2019.282","volume":"46","author":"JP Appendino","year":"2019","unstructured":"Appendino JP, Boelman C, Brna PM, et al. Position statement on the use of medical cannabis for the treatment of epilepsy in Canada. Can J Neurol Sci. 2019;46:645\u201352.","journal-title":"Can J Neurol Sci"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L, et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N Engl J Med. 2017;376:2011\u201320.","journal-title":"N Engl J Med"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","volume":"378","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Patel AD, Cross JH, et al. Effect of cannabidiol on drop seizures in the Lennox\u2013Gastaut syndrome. N Engl J Med. 2018;378:1888\u201397.","journal-title":"N Engl J Med"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","volume":"77","author":"I Miller","year":"2020","unstructured":"Miller I, Scheffer IE, Gunning B, et al. Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet Syndrome: a randomized clinical trial. JAMA Neurol. 2020;77:613\u201321.","journal-title":"JAMA Neurol"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","volume":"78","author":"EA Thiele","year":"2021","unstructured":"Thiele EA, Bebin EM, Bhathal H, et al. Add-on cannabidiol treatment for drug-resistant seizures in Tuberous Sclerosis Complex: a placebo-controlled randomized clinical trial. JAMA Neurol. 2021;78:285\u201392.","journal-title":"JAMA Neurol"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","volume":"391","author":"EA Thiele","year":"2018","unstructured":"Thiele EA, Marsh ED, French JA, et al. Cannabidiol in patients with seizures associated with Lennox\u2013Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2018;391:1085\u201396.","journal-title":"Lancet"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/acn3.621","volume":"5","author":"B McCoy","year":"2018","unstructured":"McCoy B, Wang L, Zak M, et al. A prospective open-label trial of a CBD\/THC cannabis oil in dravet syndrome. Ann Clin Transl Neurol. 2018;5:1077\u201388.","journal-title":"Ann Clin Transl Neurol"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.yebeh.2016.11.016","volume":"70","author":"TE Gaston","year":"2017","unstructured":"Gaston TE, Friedman D. Pharmacology of cannabinoids in the treatment of epilepsy. Epilepsy Behav. 2017;70:313\u20138.","journal-title":"Epilepsy Behav"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","volume":"15","author":"O Devinsky","year":"2016","unstructured":"Devinsky O, Marsh E, Friedman D, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol. 2016;15:270\u20138.","journal-title":"Lancet Neurol"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3389\/fneur.2018.00759","volume":"9","author":"FA Pamplona","year":"2018","unstructured":"Pamplona FA, da Silva LR, Coan AC. Potential clinical benefits of cbd-rich cannabis extracts over purified CBD in treatment-resistant epilepsy: observational data meta-analysis. Front Neurol. 2018;9:759.","journal-title":"Front Neurol"},{"key":"15_CR11","unstructured":"CDSCO SEC Recommendations, SEC (Neurology & Psychiatry) meeting 15.02.2023; 2023. Accessed January 25, 2025. Available at: https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadCommitteeFiles\/Recommendations%20Neurology%20&%20Psychiatry%20%2015.02.2023%20%20(1).pdf"}],"container-title":["Indian Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13312-025-00015-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13312-025-00015-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T09:44:34Z","timestamp":1744883074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13312-025-00015-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,21]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1007\/s13312-025-00015-7","relation":{},"ISSN":["0019-6061","0974-7559"],"issn-type":[{"value":"0019-6061","type":"print"},{"value":"0974-7559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,21]]},"assertion":[{"value":"21 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any relevant conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"None used for the preparation of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-Assisted Technologies in the Writing Process"}}]}}